SCYNEXIS Appoints Sanjay Subramanian CFO as Biotech Advances Rare Disease Pipeline

SCYNEXIS, Inc. (NASDAQ: SCYX) has appointed Sanjay Subramanian as chief financial officer, bringing in a biotechnology executive with more than... Read More

The post SCYNEXIS Appoints Sanjay Subramanian CFO as Biotech Advances Rare Disease Pipeline appeared first on citybiz.